Alkannoli was awarded € 3.375 million grant from IAPMEI through Project: “Creation of a production unit in Pataias for the production of pharmaceutical products based on medicinal cannabis”

Portuguese Public Agency within the Ministry of Economy, in charge of SME, competitiveness and innovation policy IAPMEI awarded Alkannoli a non-reimbursable grant of 3.375.707,54 € in May 2022 through EU Government business incentive scheme (Portugal 2020) for plant construction.

ALKANNOLI’s objectives for the present project in the time horizon 2021 to 2025 are as follows:

– To create the production facilities in Pataias;

– Obtaining EU GMP (Good Manufacturing Practice) certification;

– Securing the Infarmed license for the production and marketing of pharmaceutical products;

– Have a team of 45 employees by 2025 (with >70% highly qualified);

– To achieve a turnover greater than 10.5M euros in 2025 (100% international)

– Export to 4 European countries and achieve a sales volume in 2025 of EUR 4.5M in the German market, EUR 2.5M in Austria, EUR 2M in Switzerland and EUR 1.5M in the United Kingdom.

– To have an internal R&D department with 4 highly qualified employees dedicated 100%.

The construction process is successfully ongoing and is expected to be completed in July 2023.


WITHIN scope of a project, Eurokhan’s partner Huesker’s product HaTelit was successfully installed as an asphalt reinforcement for one of the busiest roads of Ulaanbaatar.

Due to our contract with Ulaanbaatar Investment Management UCC the Hatelit geogrid was installed on 38m2 road of Ikh Toiruu in Ulaanbaatar. 

EUROKHAN SUCCESSFULLY DELIVERED KFW VEHICLES TO BIODIVERSITY AND ADAPTATION TO CLIMATE CHANGE PROJECT OF MINISTRY OF ENVIRONMENT AND TOURISM of MONGOLIA

The vehicles were supplied to Sub-Project Protected Areas Administrations of Biodiversity and Adaptation to Climate Change Project, and it includes 3 HOWO Sewer vacuum trucks, 4 HOWO Arm roll garbage trucks, 5 Garbage containers. 

ALKANNOLI IS PROUD TO WELCOME Its NEW MEMBER Prof. fred harms as the chief medical officer

Prof. Fred Harms is a health care researcher, who studied biochemistry and medicine from 1986 to 1996 at the University of Witten/Herdecke , the University of Münster, the MD Anderson Cancer Center, Houston, Texas, USA and the University of Bangkok, graduating with an MD/PhD in tumor immunology/ oncology.

He is also a member of reputable science associations and academy’s such as New York Academy of Sciences and is also working as a board member of International Prevention Organization (IPO Brussels) since 2006.

Prof. Fred Harms was granted number of scholarships in his research area and was awarded by letter of Honor from the European Commission in Brussels, together with Dorothee Gänshirt in 2010.

Now he has joined our Alkannoli team as the Chief Medical Officer and we are looking forward to bringing high quality products to our costumers through advanced development of medical cannabis. 





Euro-Khan.com

One-step solution in energy and mining sectors.

Contact us

  • DHL Building, R. 801,
          Peace Av. 10/5 SBD-1, UB 14210,
          Mongolia
  • info@euro-khan.com
  • (+976) 11-325867